Positive rate and quantification of amyloid pathology with [ 18 F]florbetapir in the urban Chinese population.
Kun HeBinyin LiLin HuangJun ZhaoFengchun HuaTao WangJunpeng LiJie WangQi HuangKeliang ChenShasha XuShuhua RenHuawei CaiDonglang JiangJingchao HuXingmin HanYihui GuanKewei ChenQihao GuoFang XiePublished in: European radiology (2023)
• We studied amyloid pathology and related risk factors in the Chinese population. •·The overall amyloid-positive rates in individuals with clinically diagnosed AD, MCI, and NC were 85.8%, 44.5%, and 26.9%, respectively. • These overall amyloid-positive rates were in close agreement with the corresponding prevalence for other populations.